Table Of Contents

1. Market Context & Strategic Relevance

 1.1 Opening Context (Why the market matters)

  1.1.1 Why This Market Is Gaining Strategic Attention

  1.1.2 Business Decisions This Report Supports

 1.2 Scope

 1.3 Research & Methodology

2. Executive Summary

 2.1 Market Snapshot

 2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2035

 2.3 Market Size & Forecast, By Segmentation, 2022–2035

  2.3.1 Market Size By Product

  2.3.2 Market Size By Technology

  2.3.3 Market Size By Cancer Type

  2.3.4 Market Size By End User

 2.4 Market Share & Bps Analysis By Region, 2025

 2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic

 2.6 Industry CxO’s Perspective

3. Market Overview

 3.1 Market Dynamics

  3.1.1 Drivers

  3.1.2 Restraints

  3.1.3 Opportunities

  3.1.4 Key Market Trends

 3.2 Industry PESTLE Analysis

 3.3 Key Industry Forces (Porter’s) Impacting Market Growth

 3.4 Industry Supply Chain Analysis

  3.4.1 Reagent, Assay Component, Imaging Hardware & Sequencing Material Suppliers

  3.4.2 Cancer Diagnostic Instrument, Consumable and Software Manufacturers

  3.4.3 Medical Distributors, Laboratory Networks & Healthcare Procurement Channels

  3.4.4 Hospitals, Clinics, Diagnostic Laboratories & Cancer Screening Programs

 3.5 Industry Life Cycle Assessment

4. Statistical Insights & Trends Reporting

 4.1 Cancer Burden & Screening Indicators

  4.1.1 New Cancer Case Incidence

  4.1.2 Breast, Lung, Colorectal and Prostate Cancer Screening Rates

  4.1.3 Age-Standardized Cancer Prevalence

  4.1.4 Early Detection Program Coverage

 4.2 Testing Volume & Product Metrics

  4.2.1 Consumable Test Kit and Reagent Volumes

  4.2.2 Diagnostic Instrument Installed Base

  4.2.3 Imaging and Biopsy Procedure Volumes

  4.2.4 Diagnostic Software and Service Utilization

 4.3 Technology & Biomarker Trends

  4.3.1 Liquid Biopsy and Circulating Tumor DNA Adoption

  4.3.2 Next-Generation Sequencing in Oncology Diagnostics

  4.3.3 Artificial Intelligence in Imaging and Pathology

  4.3.4 Multi-Cancer Early Detection Test Development

 4.4 Reimbursement & Regulatory Environment

  4.4.1 Screening Coverage and Reimbursement Policies

  4.4.2 Regulatory Approvals for Companion and Screening Diagnostics

  4.4.3 Laboratory Developed Test Oversight

  4.4.4 Public Health Screening Guidelines

 4.5 Pricing, Access & Competitive Environment

  4.5.1 Test Pricing and Payer Coverage

  4.5.2 Hospital and Reference Laboratory Share

  4.5.3 Manufacturer Launches and Acquisitions

  4.5.4 Partnerships Between Diagnostic and Pharmaceutical Companies

5. Cancer Diagnostics Market Segmental Analysis & Forecast, By Product, 2022–2035, Value (USD Billion)

 5.1 Introduction

 5.2 Consumables

  5.2.1 Key Trends

  5.2.2 Market Size & Forecast, 2022–2035

 5.3 Instruments

 5.4 Software and Services

6. Cancer Diagnostics Market Segmental Analysis & Forecast, By Technology, 2022–2035, Value (USD Billion)

 6.1 Introduction

 6.2 In Vitro Diagnostics

  6.2.1 Key Trends

  6.2.2 Market Size & Forecast, 2022–2035

 6.3 Imaging

 6.4 Biopsy

 6.5 Others

7. Cancer Diagnostics Market Segmental Analysis & Forecast, By Cancer Type, 2022–2035, Value (USD Billion)

 7.1 Introduction

 7.2 Breast Cancer

  7.2.1 Key Trends

  7.2.2 Market Size & Forecast, 2022–2035

 7.3 Lung Cancer

 7.4 Colorectal Cancer

 7.5 Prostate Cancer

 7.6 Others

8. Cancer Diagnostics Market Segmental Analysis & Forecast, By End User, 2022–2035, Value (USD Billion)

 8.1 Introduction

 8.2 Hospitals and Clinics

  8.2.1 Key Trends

  8.2.2 Market Size & Forecast, 2022–2035

 8.3 Diagnostic Laboratories

 8.4 Others

9. Cancer Diagnostics Market Segmental Analysis & Forecast By Region, 2022–2035, Value (USD Billion)

 9.1 Introduction

 9.2 North America

  9.2.1 Key Trends

  9.2.2 Cancer Diagnostics Market Size & Forecast, By Product, 2022–2035

  9.2.3 Cancer Diagnostics Market Size & Forecast, By Technology, 2022–2035

  9.2.4 Cancer Diagnostics Market Size & Forecast, By Cancer Type, 2022–2035

  9.2.5 Cancer Diagnostics Market Size & Forecast, By End User, 2022–2035

  9.2.6 Cancer Diagnostics Market Size & Forecast, By Country, 2022–2035

   9.2.6.1 USA

   9.2.6.2 Canada

 9.3 Europe

  9.3.1 Key Trends

  9.3.2 Cancer Diagnostics Market Size & Forecast, By Product, 2022–2035

  9.3.3 Cancer Diagnostics Market Size & Forecast, By Technology, 2022–2035

  9.3.4 Cancer Diagnostics Market Size & Forecast, By Cancer Type, 2022–2035

  9.3.5 Cancer Diagnostics Market Size & Forecast, By End User, 2022–2035

  9.3.6 Cancer Diagnostics Market Size & Forecast, By Country, 2022–2035

   9.3.6.1 Germany

   9.3.6.2 UK

   9.3.6.3 France

   9.3.6.4 Italy

   9.3.6.5 Spain

   9.3.6.6 Russia

   9.3.6.7 Poland

   9.3.6.8 Rest of Europe

 9.4 Asia-Pacific

  9.4.1 Key Trends

  9.4.2 Cancer Diagnostics Market Size & Forecast, By Product, 2022–2035

  9.4.3 Cancer Diagnostics Market Size & Forecast, By Technology, 2022–2035

  9.4.4 Cancer Diagnostics Market Size & Forecast, By Cancer Type, 2022–2035

  9.4.5 Cancer Diagnostics Market Size & Forecast, By End User, 2022–2035

  9.4.6 Cancer Diagnostics Market Size & Forecast, By Country, 2022–2035

   9.4.6.1 China

   9.4.6.2 India

   9.4.6.3 Japan

   9.4.6.4 South Korea

   9.4.6.5 Australia

   9.4.6.6 ASEAN Countries

   9.4.6.7 Rest of Asia-Pacific

 9.5 Latin America

  9.5.1 Key Trends

  9.5.2 Cancer Diagnostics Market Size & Forecast, By Product, 2022–2035

  9.5.3 Cancer Diagnostics Market Size & Forecast, By Technology, 2022–2035

  9.5.4 Cancer Diagnostics Market Size & Forecast, By Cancer Type, 2022–2035

  9.5.5 Cancer Diagnostics Market Size & Forecast, By End User, 2022–2035

  9.5.6 Cancer Diagnostics Market Size & Forecast, By Country, 2022–2035

   9.5.6.1 Brazil

   9.5.6.2 Argentina

   9.5.6.3 Mexico

   9.5.6.4 Colombia

   9.5.6.5 Rest of Latin America

 9.6 Middle East & Africa

  9.6.1 Key Trends

  9.6.2 Cancer Diagnostics Market Size & Forecast, By Product, 2022–2035

  9.6.3 Cancer Diagnostics Market Size & Forecast, By Technology, 2022–2035

  9.6.4 Cancer Diagnostics Market Size & Forecast, By Cancer Type, 2022–2035

  9.6.5 Cancer Diagnostics Market Size & Forecast, By End User, 2022–2035

  9.6.6 Cancer Diagnostics Market Size & Forecast, By Country, 2022–2035

   9.6.6.1 UAE

   9.6.6.2 Saudi Arabia

   9.6.6.3 Qatar

   9.6.6.4 South Africa

   9.6.6.5 Rest of Middle East & Africa

10. Competitive Landscape

 10.1 Key Players' Positioning

 10.2 Competitive Developments

  10.2.1 Year-Wise Strategies & Development, 2022–2026

 10.3 Market Share Analysis, 2025

 10.4 Product/Service & Application Benchmarking

  10.4.1 Product/Service Specifications & Features By Key Players

  10.4.2 Product/Service Heatmap By Key Players

  10.4.3 Application Heatmap By Key Players

 10.5 Industry Start-Up & Innovation Landscape

 10.6 Key Company Profiles

  10.6.1 F. Hoffmann-La Roche Ltd

   10.6.1.1 Company Overview & Snapshot

   10.6.1.2 Product/Service Portfolio

   10.6.1.3 Key Company Financials

   10.6.1.4 Geographical Presence

   10.6.1.5 SWOT Analysis

  10.6.2 Abbott Laboratories (including Exact Sciences)

  10.6.3 Thermo Fisher Scientific Inc.

  10.6.4 Illumina, Inc.

  10.6.5 QIAGEN N.V.

  10.6.6 Hologic, Inc.

  10.6.7 Siemens Healthineers AG

  10.6.8 GE HealthCare Technologies Inc.

  10.6.9 Guardant Health, Inc.

  10.6.10 Natera, Inc.

  10.6.11 GRAIL, Inc.

  10.6.12 Myriad Genetics, Inc.

  10.6.13 Agilent Technologies, Inc.

  10.6.14 Bio-Rad Laboratories, Inc.

  10.6.15 Danaher Corporation (Leica Biosystems)

  10.6.16 Becton, Dickinson and Company

  10.6.17 Sysmex Corporation

  10.6.18 Koninklijke Philips N.V.

11. Analyst Recommendations

 11.1 SNS Insider Opportunity Map

 11.2 Industry Low-Hanging Fruit Assessment

 11.3 Market Entry & Growth Strategy

 11.4 Analyst Viewpoint & Suggestions On Market Growth

12. Assumptions

13. Disclaimer

14. Appendix

 14.1 List Of Tables

 14.2 List Of Figures